4//SEC Filing
Godshall Douglas Evan 4
Accession 0001642545-24-000044
CIK 0001642545other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:02 PM ET
Size
21.8 KB
Accession
0001642545-24-000044
Insider Transaction Report
Form 4
Godshall Douglas Evan
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-02-15$233.54/sh−200$46,708→ 164,193 total - Sale
Common Stock
2024-02-15$235.21/sh−600$141,126→ 163,593 total - Sale
Common Stock
2024-02-15$236.13/sh−831$196,224→ 162,762 total - Sale
Common Stock
2024-02-15$230.86/sh−2,800$646,408→ 167,172 total - Sale
Common Stock
2024-02-15$232.74/sh−792$184,330→ 164,393 total - Exercise/Conversion
Common Stock
2024-02-15$3.42/sh+10,000$34,160→ 172,762 total - Sale
Common Stock
2024-02-15$231.74/sh−1,987$460,467→ 165,185 total - Sale
Common Stock
2024-02-15$228.28/sh−560$127,837→ 172,202 total - Sale
Common Stock
2024-02-15$229.82/sh−2,230$512,499→ 169,972 total - Exercise/Conversion
Stock Option
2024-02-15−10,000→ 294,799 totalExercise: $3.42Exp: 2027-05-09→ Common Stock (10,000 underlying)
Footnotes (10)
- [F1]All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 05/25/2023.
- [F10]Fully vested.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $227.95 to $228.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $230.08. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.32 to $231.24. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.35 to $232.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F6]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $232.37 to $233.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F7]All reported securities were sold at a price of $233.54.
- [F8]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $234.91 to $235.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F9]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $235.99 to $236.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Documents
Issuer
Shockwave Medical, Inc.
CIK 0001642545
Entity typeother
Related Parties
1- filerCIK 0001404227
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:02 PM ET
- Size
- 21.8 KB